BCG Vaccine for Tuberculosis (TB) provides immunity or protection against tuberculosis (TB). The vaccine may be given to persons at high risk of developing TB.
This report contains market size and forecasts of BCG Vaccine for Tuberculosis (TB) in global, including the following market information:
Global BCG Vaccine for Tuberculosis (TB) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global BCG Vaccine for Tuberculosis (TB) Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five BCG Vaccine for Tuberculosis (TB) companies in 2021 (%)
The global BCG Vaccine for Tuberculosis (TB) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Immune Type Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of BCG Vaccine for Tuberculosis (TB) include Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, AJ Vaccines, Serum Institute of India, Intervax, GSBPL and Statens Serum Institute, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Publisher has surveyed the BCG Vaccine for Tuberculosis (TB) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global BCG Vaccine for Tuberculosis (TB) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global BCG Vaccine for Tuberculosis (TB) Market Segment Percentages, by Type, 2021 (%)
Immune Type
Therapy Type
Global BCG Vaccine for Tuberculosis (TB) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global BCG Vaccine for Tuberculosis (TB) Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global BCG Vaccine for Tuberculosis (TB) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global BCG Vaccine for Tuberculosis (TB) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies BCG Vaccine for Tuberculosis (TB) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies BCG Vaccine for Tuberculosis (TB) revenues share in global market, 2021 (%)
Key companies BCG Vaccine for Tuberculosis (TB) sales in global market, 2017-2022 (Estimated), (K Units)
Key companies BCG Vaccine for Tuberculosis (TB) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
AJ Vaccines
Serum Institute of India
Intervax
GSBPL
Statens Serum Institute
Biomed Lublin
ANLIS Malbran
Funda??o Ataulpho de Paiva
BB-NCIPD
Taj Pharmaceuticals
Bio Farma
Microgen
Torlakinstitut
Institut Pasteur de Tunis
IVAC
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 BCG Vaccine for Tuberculosis (TB) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global BCG Vaccine for Tuberculosis (TB) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global BCG Vaccine for Tuberculosis (TB) Overall Market Size
2.1 Global BCG Vaccine for Tuberculosis (TB) Market Size: 2021 VS 2028
2.2 Global BCG Vaccine for Tuberculosis (TB) Revenue, Prospects & Forecasts: 2017-2028
2.3 Global BCG Vaccine for Tuberculosis (TB) Sales: 2017-2028
3 Company Landscape
3.1 Top BCG Vaccine for Tuberculosis (TB) Players in Global Market
3.2 Top Global BCG Vaccine for Tuberculosis (TB) Companies Ranked by Revenue
3.3 Global BCG Vaccine for Tuberculosis (TB) Revenue by Companies
3.4 Global BCG Vaccine for Tuberculosis (TB) Sales by Companies
3.5 Global BCG Vaccine for Tuberculosis (TB) Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 BCG Vaccine for Tuberculosis (TB) Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers BCG Vaccine for Tuberculosis (TB) Product Type
3.8 Tier 1, Tier 2 and Tier 3 BCG Vaccine for Tuberculosis (TB) Players in Global Market
3.8.1 List of Global Tier 1 BCG Vaccine for Tuberculosis (TB) Companies
3.8.2 List of Global Tier 2 and Tier 3 BCG Vaccine for Tuberculosis (TB) Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global BCG Vaccine for Tuberculosis (TB) Market Size Markets, 2021 & 2028
4.1.2 Immune Type
4.1.3 Therapy Type
4.2 By Type - Global BCG Vaccine for Tuberculosis (TB) Revenue & Forecasts
4.2.1 By Type - Global BCG Vaccine for Tuberculosis (TB) Revenue, 2017-2022
4.2.2 By Type - Global BCG Vaccine for Tuberculosis (TB) Revenue, 2023-2028
4.2.3 By Type - Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share, 2017-2028
4.3 By Type - Global BCG Vaccine for Tuberculosis (TB) Sales & Forecasts
4.3.1 By Type - Global BCG Vaccine for Tuberculosis (TB) Sales, 2017-2022
4.3.2 By Type - Global BCG Vaccine for Tuberculosis (TB) Sales, 2023-2028
4.3.3 By Type - Global BCG Vaccine for Tuberculosis (TB) Sales Market Share, 2017-2028
4.4 By Type - Global BCG Vaccine for Tuberculosis (TB) Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global BCG Vaccine for Tuberculosis (TB) Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global BCG Vaccine for Tuberculosis (TB) Revenue & Forecasts
5.2.1 By Application - Global BCG Vaccine for Tuberculosis (TB) Revenue, 2017-2022
5.2.2 By Application - Global BCG Vaccine for Tuberculosis (TB) Revenue, 2023-2028
5.2.3 By Application - Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share, 2017-2028
5.3 By Application - Global BCG Vaccine for Tuberculosis (TB) Sales & Forecasts
5.3.1 By Application - Global BCG Vaccine for Tuberculosis (TB) Sales, 2017-2022
5.3.2 By Application - Global BCG Vaccine for Tuberculosis (TB) Sales, 2023-2028
5.3.3 By Application - Global BCG Vaccine for Tuberculosis (TB) Sales Market Share, 2017-2028
5.4 By Application - Global BCG Vaccine for Tuberculosis (TB) Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global BCG Vaccine for Tuberculosis (TB) Market Size, 2021 & 2028
6.2 By Region - Global BCG Vaccine for Tuberculosis (TB) Revenue & Forecasts
6.2.1 By Region - Global BCG Vaccine for Tuberculosis (TB) Revenue, 2017-2022
6.2.2 By Region - Global BCG Vaccine for Tuberculosis (TB) Revenue, 2023-2028
6.2.3 By Region - Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share, 2017-2028
6.3 By Region - Global BCG Vaccine for Tuberculosis (TB) Sales & Forecasts
6.3.1 By Region - Global BCG Vaccine for Tuberculosis (TB) Sales, 2017-2022
6.3.2 By Region - Global BCG Vaccine for Tuberculosis (TB) Sales, 2023-2028
6.3.3 By Region - Global BCG Vaccine for Tuberculosis (TB) Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America BCG Vaccine for Tuberculosis (TB) Revenue, 2017-2028
6.4.2 By Country - North America BCG Vaccine for Tuberculosis (TB) Sales, 2017-2028
6.4.3 US BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.4.4 Canada BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.4.5 Mexico BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe BCG Vaccine for Tuberculosis (TB) Revenue, 2017-2028
6.5.2 By Country - Europe BCG Vaccine for Tuberculosis (TB) Sales, 2017-2028
6.5.3 Germany BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.5.4 France BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.5.5 U.K. BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.5.6 Italy BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.5.7 Russia BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.5.8 Nordic Countries BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.5.9 Benelux BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia BCG Vaccine for Tuberculosis (TB) Revenue, 2017-2028
6.6.2 By Region - Asia BCG Vaccine for Tuberculosis (TB) Sales, 2017-2028
6.6.3 China BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.6.4 Japan BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.6.5 South Korea BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.6.6 Southeast Asia BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.6.7 India BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America BCG Vaccine for Tuberculosis (TB) Revenue, 2017-2028
6.7.2 By Country - South America BCG Vaccine for Tuberculosis (TB) Sales, 2017-2028
6.7.3 Brazil BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.7.4 Argentina BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa BCG Vaccine for Tuberculosis (TB) Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa BCG Vaccine for Tuberculosis (TB) Sales, 2017-2028
6.8.3 Turkey BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.8.4 Israel BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.8.5 Saudi Arabia BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
6.8.6 UAE BCG Vaccine for Tuberculosis (TB) Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.1.4 Merck BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2017-2022)
7.1.5 Merck Key News
7.2 Sanofi Pasteur
7.2.1 Sanofi Pasteur Corporate Summary
7.2.2 Sanofi Pasteur Business Overview
7.2.3 Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.2.4 Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2017-2022)
7.2.5 Sanofi Pasteur Key News
7.3 Japan BCG Lab
7.3.1 Japan BCG Lab Corporate Summary
7.3.2 Japan BCG Lab Business Overview
7.3.3 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.3.4 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2017-2022)
7.3.5 Japan BCG Lab Key News
7.4 China National Biotec
7.4.1 China National Biotec Corporate Summary
7.4.2 China National Biotec Business Overview
7.4.3 China National Biotec BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.4.4 China National Biotec BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2017-2022)
7.4.5 China National Biotec Key News
7.5 AJ Vaccines
7.5.1 AJ Vaccines Corporate Summary
7.5.2 AJ Vaccines Business Overview
7.5.3 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.5.4 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2017-2022)
7.5.5 AJ Vaccines Key News
7.6 Serum Institute of India
7.6.1 Serum Institute of India Corporate Summary
7.6.2 Serum Institute of India Business Overview
7.6.3 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.6.4 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2017-2022)
7.6.5 Serum Institute of India Key News
7.7 Intervax
7.7.1 Intervax Corporate Summary
7.7.2 Intervax Business Overview
7.7.3 Intervax BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.7.4 Intervax BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2017-2022)
7.7.5 Intervax Key News
7.8 GSBPL
7.8.1 GSBPL Corporate Summary
7.8.2 GSBPL Business Overview
7.8.3 GSBPL BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.8.4 GSBPL BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2017-2022)
7.8.5 GSBPL Key News
7.9 Statens Serum Institute
7.9.1 Statens Serum Institute Corporate Summary
7.9.2 Statens Serum Institute Business Overview
7.9.3 Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.9.4 Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2017-2022)
7.9.5 Statens Serum Institute Key News
7.10 Biomed Lublin
7.10.1 Biomed Lublin Corporate Summary
7.10.2 Biomed Lublin Business Overview
7.10.3 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.10.4 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2017-2022)
7.10.5 Biomed Lublin Key News
7.11 ANLIS Malbran
7.11.1 ANLIS Malbran Corporate Summary
7.11.2 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Business Overview
7.11.3 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Major Product Offerings
7.11.4 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Sales and Revenue in Global (2017-2022)
7.11.5 ANLIS Malbran Key News
7.12 Funda